- Thinly traded nano cap Echo Therapeutics (OTC:ECTE -21.8%) eases on 50% higher volume in response to its announcement that trading in its stock will be suspended tomorrow before the open from trading on Nasdaq.
- Henceforward, shares will trade in the OTCQB Venture Market under the same symbol.